| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/24/2003 | WO2003059248A2 Pigment epithelium derived factor from human plasma and methods of use thereof |
| 07/24/2003 | WO2003059245A2 Method of treating asthma |
| 07/24/2003 | WO2003059148A2 Gene expression profiles in stomach cancer |
| 07/24/2003 | WO2003059083A1 Whey protein hydrolysates and peptide fractions derived from whey protein with a bioactive action, obtained by hydrolysis with proteases |
| 07/24/2003 | WO2003059072A1 Cultured and encapsulated pancreatic stem cells |
| 07/24/2003 | WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 07/24/2003 | WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 07/24/2003 | WO2003045332A3 Methods and compositions for treating lesions of the respiratory epithelium |
| 07/24/2003 | WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 07/24/2003 | WO2003029291A3 Pegylated and diglycosylated erythropoietin |
| 07/24/2003 | WO2003027140A3 Identification of s. typhimurium genes by software-based genome comparison |
| 07/24/2003 | WO2003022884A3 Methods for construction and screening of libraries of chemokine variants |
| 07/24/2003 | WO2003018612A3 Extracellular messengers |
| 07/24/2003 | WO2003011895A3 Compositions and methods for modulation of immune responses |
| 07/24/2003 | WO2003011117A3 Methods and compositions for treating and preventing distal bowel lesions |
| 07/24/2003 | WO2003006661A3 Transgenic plants expressing cobalamin binding proteins |
| 07/24/2003 | WO2003004526B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines |
| 07/24/2003 | WO2003002091A3 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same |
| 07/24/2003 | WO2002102994A3 Human secreted proteins |
| 07/24/2003 | WO2002094873A3 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use |
| 07/24/2003 | WO2002088358A3 Human fibroblast growth factor-related compositions |
| 07/24/2003 | WO2002077156A3 Protection-of-telomere-1 (pot-1) protein and encoding polynucleotides |
| 07/24/2003 | WO2002074807A3 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 07/24/2003 | WO2002066640A3 Zinc finger binding domains for nucleotide sequence ann |
| 07/24/2003 | WO2002060942A3 Protein modification and maintenance molecules |
| 07/24/2003 | WO2002059323A3 Aminoacyl trna synthetases |
| 07/24/2003 | WO2002059300A3 Double-stranded rna-mediated gene suppression |
| 07/24/2003 | WO2002057480A3 Cell-proliferative disorder treatments using cre decoy oligomers, bcl-2 antisense and hybrid oligomers |
| 07/24/2003 | WO2002055682A3 56634, a novel human phosphatidylinositol 4-phosphate 5-kinase family member and uses thereof |
| 07/24/2003 | WO2002053770A3 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/24/2003 | WO2002053719A3 Cytoskeleton-associated proteins |
| 07/24/2003 | WO2002051979A3 Method to remove citrate and aluminum from proteins |
| 07/24/2003 | WO2002050278A3 Novel human secreted proteins and polynucleotides encoding the same |
| 07/24/2003 | WO2002050276A3 Proteins and nucleic acids encoding same |
| 07/24/2003 | WO2002050275A3 Proteins and nucleic acids encoding same |
| 07/24/2003 | WO2002049575A3 Method and composition for the treatment of diabetic neuropathy |
| 07/24/2003 | WO2002044417A3 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 07/24/2003 | WO2002036634A3 Gene regulation therapy involving ferritin |
| 07/24/2003 | WO2002033087A3 Proteins and nucleic acids encoding same |
| 07/24/2003 | WO2002030446A3 Reduction or prevention of post-surgical adhesion formation with fibrinogen |
| 07/24/2003 | WO2002028410A9 Perilipin as a target for regulation of body weight, muscle mass and diabetes |
| 07/24/2003 | WO2002018954A3 Inhibition of cmv infection and dissemination |
| 07/24/2003 | WO2001079447A8 Novel bone marrow nucleic acids and polypeptides |
| 07/24/2003 | US20030140359 Non-human mammals comprising cells expressing vector-borne rat PTTG carboxy-terminal-related DNA |
| 07/24/2003 | US20030140358 Transgenic mammal coding serine protease inhibitor which is expressed in mammary gland tissue and products for treating immunosuppression disorders and angioedema |
| 07/24/2003 | US20030140356 Mimetic of functional transforming growth factor/myostatin (MSTN 350); for increasing/inhibiting muscle growth in animals; veterinary medicine; antiproliferative/anticarcinogeneic agents |
| 07/24/2003 | US20030139811 Orthopedic hardware with a sustained release device configured to release a compound over an extended period of time and is attachable to a portion of the body |
| 07/24/2003 | US20030139591 Isolation and use of tissue growth-inducing Frzb protein |
| 07/24/2003 | US20030139588 Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 07/24/2003 | US20030139585 Oligonucleotide derivatives which are at least partly double-stranded and which have a 2'5'-linked oligonucleotide residue on at least one 3' end; use in formulating pharmaceutical for tumor therapy, infectious diseases |
| 07/24/2003 | US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents |
| 07/24/2003 | US20030139582 Composition containing biologically active polypeptides suitable for the oral administration |
| 07/24/2003 | US20030139581 Protocadherin materials and methods |
| 07/24/2003 | US20030139580 Tumour necrosis factor binding ligands |
| 07/24/2003 | US20030139578 Monoclonal antibody for use in diagnosis, prognosis, treatment and evaluation of neoplastic, immune and neuronal disorders; drug screening |
| 07/24/2003 | US20030139577 Tumour necrosis factor binding ligands |
| 07/24/2003 | US20030139575 Cytokine immunoconjugates |
| 07/24/2003 | US20030139574 Active hedgehog protein conjugate |
| 07/24/2003 | US20030139572 Novel compounds |
| 07/24/2003 | US20030139571 G protein-coupled chemokine receptor for prevention and detection of viral infection; viricides |
| 07/24/2003 | US20030139410 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030139374 Combined methods for tumor vasculature coagulation and treatment |
| 07/24/2003 | US20030139367 Gene therapy composition for treating viral myocarditis |
| 07/24/2003 | US20030139366 Inhibition of Smad3 to prevent fibrosis and improve wound healing |
| 07/24/2003 | US20030139365 Expression and export of angiogenesis inhibitors as immunofusins |
| 07/24/2003 | US20030139364 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 07/24/2003 | US20030139363 Methods and compositions for RNAi mediated inhibition of viral gene expression in mammals |
| 07/24/2003 | US20030139361 Organ grafting; antiinflammatory agents, autoimmune disease |
| 07/24/2003 | US20030139360 Prevention gene expression; genetic engineering |
| 07/24/2003 | US20030139359 Hybrid nucleic acids; prevent gene expression in tissue |
| 07/24/2003 | US20030139358 Anticancer agents; genetic engineering |
| 07/24/2003 | US20030139348 Animal growth regulators |
| 07/24/2003 | US20030139347 Pralmorelin-containing nasal drop preparations |
| 07/24/2003 | US20030139346 Polymer stabilized neuropeptides |
| 07/24/2003 | US20030139345 Synthetic peptides and methods for treating cancer invasion and metastasis |
| 07/24/2003 | US20030139344 Apoptosis gene; anticancer agents; ovaries |
| 07/24/2003 | US20030139343 Regulation of human hm74-like g protein coupled receptor |
| 07/24/2003 | US20030139342 Method of inducing vitreous detachment |
| 07/24/2003 | US20030139341 Regulation of human lgr4-like g protein -coupled receptor |
| 07/24/2003 | US20030139340 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 07/24/2003 | US20030139339 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor ( TFPI) |
| 07/24/2003 | US20030139335 Diagnosis of premature infants; collagen forming |
| 07/24/2003 | US20030139333 Methods and compositions for promoting angiogenesis |
| 07/24/2003 | US20030139331 Treatment of cancer by reduction of intracellular energy and pyrimidines |
| 07/24/2003 | US20030139330 Transcription factors containing two potential dna binding motifs |
| 07/24/2003 | US20030139329 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030139328 Complexing; modulating biological activation |
| 07/24/2003 | US20030139327 Nucleic acids, proteins, and antibodies |
| 07/24/2003 | US20030139326 Antiinflammatory agents; autoimmune disease |
| 07/24/2003 | US20030139325 Complex comprising OCIF and polysaccharide |
| 07/24/2003 | US20030139324 Cancer diagnosis, therapy; genetic engineered polypeptide |
| 07/24/2003 | US20030138954 Self-inactivating plasmid/vector; gene therapy; treating hematological disorders; anticarcinogenic agents |
| 07/24/2003 | US20030138952 Antisense modulation of PCTAIRE protein kinase 1 expression |
| 07/24/2003 | US20030138949 Methods for the regeneration of pancreatic islets and expansion of pancreatic endocrine cells |
| 07/24/2003 | US20030138946 Genetically engineered major histocompatibiity complex antigen presenting cells for activating CD8 lymphocytes and producing cytokines and becoming cytotoxic; antitumor agents |
| 07/24/2003 | US20030138932 Comprises enzymatic glycoproteins for use as antitumor/antiproliferative agents; enzyme inhibitors; drug screening |
| 07/24/2003 | US20030138930 Retinol dehydrogenase polypeptide for treating vision defects, epidermal/skin disorders or enhancing skin health |
| 07/24/2003 | US20030138926 Novel polynucleotides and polypeptides encoded thereby |
| 07/24/2003 | US20030138925 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |